Vanguard Capital Management’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.9M Sell
676,926
-17,293
-2% -$382K ﹤0.01% 2704
2026
Q2
$23M Sell
694,219
-26,223
-4% -$818K ﹤0.01% 2367
2026
Q1
$17.9M Buy
+720,442
New +$13M ﹤0.01% 2406

Other funds holding STRO

Vanguard Capital Management's STRO Position: Q3 2026 in Review

Vanguard Capital Management reduced its Sutro Biopharma (STRO) stake by 2.5% in Q3 2026, selling an estimated $382K and leaving 676,926 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2704.

Vanguard Capital Management first reported a position in STRO in Q1 2026 and has held it in 3 quarters since. The position peaked at $23M in Q2 2026. 107 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • Vanguard Capital Management held 676,926 shares of Sutro Biopharma worth $10.9M as of Q3 2026.
  • Vanguard Capital Management sold 17,293 Sutro Biopharma shares in Q3 2026, an estimated $382K.
  • Sutro Biopharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2704 holding.
  • Vanguard Capital Management first reported a position in Sutro Biopharma in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Sutro Biopharma position peaked at $23M in Q2 2026.
  • 107 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.